134 related articles for article (PubMed ID: 37726978)
1. Telehealth use and its impact on clinical outcomes in patients with type 2 diabetes during the COVID-19 pandemic.
Shao Y; Shi L; Nauman E; Price-Haywood E; Stoecker C
Diabetes Obes Metab; 2024 Jan; 26(1):118-125. PubMed ID: 37726978
[TBL] [Abstract][Full Text] [Related]
2. Telehealth and Medicare Type 2 Diabetes Care Outcomes: Evidence From Louisiana.
Walker B; Stoecker C; Shao Y; Nauman E; Fort D; Shi L
Med Care; 2023 Apr; 61(Suppl 1):S77-S82. PubMed ID: 36893422
[TBL] [Abstract][Full Text] [Related]
3. Disparities in routine healthcare utilization disruptions during COVID-19 pandemic among veterans with type 2 diabetes.
Adhikari S; Titus AR; Baum A; Lopez P; Kanchi R; Orstad SL; Elbel B; Lee DC; Thorpe LE; Schwartz MD
BMC Health Serv Res; 2023 Jan; 23(1):41. PubMed ID: 36647113
[TBL] [Abstract][Full Text] [Related]
4. The impact of a telehealth intervention on the metabolic profile of diabetes mellitus patients during the COVID-19 pandemic - A randomized clinical trial.
Franco DW; Alessi J; de Carvalho TR; Kobe GL; Oliveira GB; Knijnik CP; Amaral B; Becker AS; Schaan BD; Telo GH
Prim Care Diabetes; 2022 Dec; 16(6):745-752. PubMed ID: 36266163
[TBL] [Abstract][Full Text] [Related]
5. Access to telehealth and changes in diabetes care patterns during the pandemic: evidence from a large integrated health system in the Southeast USA.
Oviedo SA; McDonald B; Gander JC; Ali MK; Harding JL
BMJ Open Diabetes Res Care; 2024 Feb; 12(1):. PubMed ID: 38413175
[TBL] [Abstract][Full Text] [Related]
6. Effect of a Comprehensive Telehealth Intervention vs Telemonitoring and Care Coordination in Patients With Persistently Poor Type 2 Diabetes Control: A Randomized Clinical Trial.
Crowley MJ; Tarkington PE; Bosworth HB; Jeffreys AS; Coffman CJ; Maciejewski ML; Steinhauser K; Smith VA; Dar MS; Fredrickson SK; Mundy AC; Strawbridge EM; Marcano TJ; Overby DL; Majette Elliott NT; Danus S; Edelman D
JAMA Intern Med; 2022 Sep; 182(9):943-952. PubMed ID: 35877092
[TBL] [Abstract][Full Text] [Related]
7. Meeting the needs of rural veterans through rapid implementation of pharmacist-provided telehealth management of diabetes during the COVID-19 pandemic.
Baum SG; Coan LM; Porter AK
J Am Pharm Assoc (2003); 2023; 63(2):623-627. PubMed ID: 36379866
[TBL] [Abstract][Full Text] [Related]
8. Association between telemedicine use and diabetes risk factor assessment and control in a primary care network.
Grauer A; Duran AT; Liyanage-Don NA; Torres-Deas LM; Metser G; Moise N; Kronish IM; Ye S
J Endocrinol Invest; 2022 Sep; 45(9):1749-1756. PubMed ID: 35596919
[TBL] [Abstract][Full Text] [Related]
9. Noninferiority of Telemedicine Delivered Compared With In-person Diabetes Self-Management Education and Support (DSMES) During Covid-19 Pandemic in Thailand.
Areevut C; Sakmanarit J; Tachanivate P; Jerawatana R; Vittayakasemsont K; Pookate W; Kamnirdsittiseree P; Savetkairop B; Saibuathong N; Chanchat S
Asia Pac J Public Health; 2022 Nov; 34(8):799-803. PubMed ID: 36124368
[TBL] [Abstract][Full Text] [Related]
10. Pharmacist telehealth in an underserved urban population with type 2 diabetes mellitus.
Mukherjee SM; DelDotto D; Patel A; Silva MA
Res Social Adm Pharm; 2023 Nov; 19(11):1465-1470. PubMed ID: 37507339
[TBL] [Abstract][Full Text] [Related]
11. A comparison between different patient groups for diabetes management during phases of the COVID-19 pandemic: a retrospective cohort study in Ontario, Canada.
Senthinathan A; Tu K; Stephenson E; O'Neill B; Lipscombe L; Ji C; Butt DA; Apajee J; Train A; Crampton N
BMC Prim Care; 2024 Jan; 25(1):43. PubMed ID: 38280984
[TBL] [Abstract][Full Text] [Related]
12. Utilisation of telehealth for outpatient diabetes management during COVID-19 pandemic: how did the patients fare?
Wong VW; Wang A; Manoharan M
Intern Med J; 2021 Dec; 51(12):2021-2026. PubMed ID: 34227718
[TBL] [Abstract][Full Text] [Related]
13. The impact of telemedicine on patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia: Findings and implications.
M Tourkmani A; J ALHarbi T; Rsheed AMB; Alrasheedy AA; ALMadani W; ALJuraisi F; AlOtaibi AF; AlHarbi M; AlAbood AF; Alshaikh AA
J Telemed Telecare; 2023 Jun; 29(5):390-398. PubMed ID: 33525952
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Telehealth Utilization and Subsequent Inpatient Stays and Emergency Visits During the COVID-19 Pandemic Among Patients with Type 2 Diabetes: Evidence from Louisiana.
Walker B; Stoecker C; Shao Y; Nauman E; Kabagambe EK; Shi L
Telemed J E Health; 2024 Jan; 30(1):278-283. PubMed ID: 37405746
[No Abstract] [Full Text] [Related]
15. Telemedicine management of type 2 diabetes mellitus in obese and overweight young and middle-aged patients during COVID-19 outbreak: A single-center, prospective, randomized control study.
Yin W; Liu Y; Hu H; Sun J; Liu Y; Wang Z
PLoS One; 2022; 17(9):e0275251. PubMed ID: 36174028
[TBL] [Abstract][Full Text] [Related]
16. Greater Telehealth Use Results in Increased Visit Frequency and Lower Physician Related-Distress in Adolescents and Young Adults With Type 1 Diabetes.
Garcia JF; Faye E; Reid MW; Pyatak EA; Fox DS; Bisno DI; Salcedo-Rodriguez E; Sanchez AT; Hiyari S; Fogel JL; Raymond JK
J Diabetes Sci Technol; 2023 Jul; 17(4):878-886. PubMed ID: 36546602
[TBL] [Abstract][Full Text] [Related]
17. Diabetes consultation versus diabetes education in patients with poor glycaemic control: A telemedicine intervention study.
Nyenwe EA; Ashby S; Tidwell J
J Telemed Telecare; 2022 Oct; 28(9):687-693. PubMed ID: 32990153
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Pharmacist-Led Telemedicine on A1c Reduction During the COVID-19 Pandemic.
Ahmed F; Hammad S; Redmann O; Smith C; Edwards C; Kader C; Hammoudeh D; Zeidan R
Telemed J E Health; 2024 Jan; 30(1):166-172. PubMed ID: 37294586
[No Abstract] [Full Text] [Related]
19. Trends and disparities in telehealth use among Louisiana Medicaid beneficiaries with type 2 diabetes.
Shao Y; Shi L; Nauman E; Price-Haywood E; Stoecker C
Diabetes Obes Metab; 2023 Sep; 25(9):2680-2688. PubMed ID: 37340211
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Follow-Up Appointment No-Shows Before and During COVID Among Adults with Type 2 Diabetes.
Sun CA; Perrin N; Maruthur N; Renda S; Levin S; Han HR
Telemed J E Health; 2023 Jun; 29(6):851-865. PubMed ID: 36342782
[No Abstract] [Full Text] [Related]
[Next] [New Search]
